Sanofi Secures Deal to Supply Plavix to U.S.

Following a [$196.89 million] investment in its Newcastle manufacturing plant, a global pharmaceutical company has secured the right to supply the U.S. market with a drug made on Tyneside – for the first time.
The Journal